Skip to content

COVID-19 and Pregnancy

(UPDATE 09/16/2024)

Covid disease has become endemic with seasonal flares.  Pregnant women do not appear to be at higher likelihood to acquire the coronavirus than non-pregnant women, but the disease course of COVID-19 may be more severe. For this reason, take extra care in preventing virus exposure.  More than 50% of women who get ill from the coronavirus got it from someone who did not have symptoms at the time.  You have to do more than just “avoid sick people”!  Vaccination is your best defense against severe disease, hospitalization, prenatal complications, and death.

If you have COVID-19 symptoms or you are concerned that you may have been exposed to COVID-19, please get tested. We cannot see patients with symptoms of Covid, or test patients for Covid. Your primary care provider may do testing in their office.   Home tests are adequate as well, and consider swabbing both your throat and nose.  In general, if you are experiencing fever, cough or shortness of breath, we request you call the office to postpone your appointment.

If you do acquire the newest strains of COVID-19, it is likely that you will only have mild disease (no shortness of breath) and can remain at home. Notify our office if you have COVID-19. We will have regular telephone contact with you if needed, assessing for worsening of your illness and the need for hospital care. We will also reschedule your prenatal appointments to accommodate your isolation.

IF YOU GET COVID DISEASE WHILE PREGNANT…

Notify

Please notify our office if you get Covid; this can wait until regular business hours, or just send a message in the Patient Portal.  We like to keep track of your progressing course, give you practical health advice, and assist in rescheduling appointments.

Isolate

You should isolate yourself from others, to reduce the risk of infection (although, most already transmit the virus several days before a positive test).

Home Care

The omicron variants dominate our community at this time.  Fortunately, instead of pneumonia, omicron symptoms are mainly sore throat and nasal congestion. Fatigue, headache, diarrhea, and a brief fever are common too. Make sure that you are really good about hydration.  You may take any of the cold preparations on our safe-medications list. Call the office or seek emergency room care if you experience worsening breathing ability, unremitting fever >102°F despite appropriate use of acetaminophen, inability to tolerate oral hydration and medications, persistent chest pain with deep breaths, confusion, or obstetric complications (e.g., preterm contractions, vaginal bleeding, rupture of membranes, decreased fetal activity).  Persistent respiratory rate ≥20 to 24 breaths/minute and/or heart rate >100 beats per minute are also signs of worsening disease. Those in the third trimester should perform fetal kick counts and report decreased fetal movement.

Therapy

Pregnancy itself increases your risk for severe disease, hospitalization, and death.  There is some limited evidence that it may also increase the likelihood of preterm birth and stillbirth in unvaccinated women. Therapeutics only modestly improve symptoms, but they do shorten the course of your illness and reduce hospitalization and death by 89 percent!  Oral anti-viral pills are appropriate for all pregnant women, and can be especially important for women who have other risk factors (hypertension, kidney disease, asthma, diabetes, obesity, weak immune system, and others).
  • Paxlovid (nirmatrelvir/ritonavir) is an oral antiviral pill combination.  The medication has received an Emergency Use Authorization in the United States, including for pregnant patients. In a trial in adult outpatients with at least one risk factor for severe disease, nirmatrelvir-ritonavir, administered within three days of symptom onset, reduced the risk of hospitalization or death. The Society for Maternal Fetal Medicine issued a statement supporting the use of Paxlovid in pregnancy. Although only minimal reproductive safety data from animal studies are available for nirmatrelvir (e.g., reduced fetal body weights in rabbits when exposed to doses 10-fold higher than authorized human maternal doses), extensive data are available for ritonavir in patients with HIV and no increased risk of overall teratogenic effects has been observed following first-trimester exposure. There are no data on the presence of nirmatrelvir in breast milk, the effects on the breastfed infant, or the effects on milk production. Limited data suggest that ritonavir is present in breast milk, but no information is available on the effects on the breastfed infant or the effects on milk production. Lactation is not a contraindication to use, but interruption of breast feeding during maternal treatment may be prudent.
    • Paxlovid is now our preferred therapeutic for pregnant women.  It has the equivalent effect as monoclonal antibody treatment, but is more available and requires fewer resources. Side-effects are very rare (<1%) and include diarrhea, altered taste, metallic taste, hypertension, and muscle aches.
      > The typical dose is 300 mg nirmatrelvir (two 150 mg tablets) with 100 mg ritonavir (one 100 mg tablet) — with all three tablets taken together, twice daily for 5 days (30 pills in total).
    • Paxlovid is now available at most major community pharmacies.
    • If you would like Arbor ObGyn to prescribe the antiviral pill treatment, call us or send a portal message indicating your desire to take Paxlovid, AND you pharmacy location.
    • Please review the UNC Health Paxlovid Infosheet, and emergency use Patient Fact Sheet. Also, view a useful video from UNC Health on Paxlovid therapeutic pills.

Prenatal Care

In general, your care after recovering from COVID-19 will not differ from your original prenatal care plan.  No additional fetal testing such as growth ultrasounds, non-stress tests or biophysical profiles are recommended.

Delivery

Ideally, birth will occur sometime after recovery. Induction of labor and cesarean birth are not recommended as a treatment plan for a history of asymptomatic or non-severe prenatal Covid infection.

 

ABOUT THE COVID-19 VACCINE

Should pregnant women get the Covid-19 Vaccine?

Yes. Pregnant women who are eligible recipients should get the vaccine (updated guidance 01/26/22).

Can I breastfeed after the Covid-19 Vaccine?

Yes. The Academy of Breastfeeding Medicine (ABM) states that the vaccine is safe for lactating women.

Will the Covid-19 Vaccine cause infertility?

No. The American Society for Reproductive Medicine (ASRM) states that women planning for pregnancy should not avoid the vaccine if they are eligible recipients.
Back To Top